Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis.

Trial Profile

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2018

At a glance

  • Drugs Insulin; Insulin glargine; Insulin glulisine; Insulin suspension isophane
  • Indications Diabetes mellitus; Diabetic ketoacidosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2009 Actual number of patients changed from 60 to 74 as reported by ClinicalTrials.gov.
    • 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes
    • 19 Aug 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top